te Sun Pharma: Today Latest News, Photos, Videos about Sun Pharma - Zee Business

हिंदी में पढ़ें

Sun Pharma

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Thu, Jan 18, 2024

On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Wed, Jan 17, 2024

Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Wed, Jan 03, 2024

Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.

TRENDING NOW

Two killed in fire at Sun Pharma factory

Two killed in fire at Sun Pharma factory

Wed, Dec 28, 2016

A fire broke out in the Sun Pharma factory in Ahmednagar on Wednesday, claiming two lives while two were injured.

Sun Pharma arm picks up 14.6% stake in US company for $13 million

Sun Pharma arm picks up 14.6% stake in US company for $13 million

Fri, Dec 23, 2016

"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%

Thu, Dec 22, 2016

"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.

FDA made nine observations post Halol unit inspection: Sun Pharma

FDA made nine observations post Halol unit inspection: Sun Pharma

Thu, Dec 08, 2016

The company did not disclose the observations made by the USFDA.

Sun Pharma to acquire Russia's JSC Biosintez; shares up

Sun Pharma to acquire Russia's JSC Biosintez; shares up

Wed, Nov 23, 2016

“With this move, we plan to acquire the product portfolio and local manufacturing capability in Russia which would help in expanding our presence in Russia and serving Russia pharmaceutical market more effectively,” Sun Pharma said in a statement.

Higher spending, urbanisation to boost domestic pharma markets: Fitch

Higher spending, urbanisation to boost domestic pharma markets: Fitch

Tue, Nov 15, 2016

Increase in consumer spending in India would provide a boost to domestic pharmaceutical companies over the medium term, credit rating agency Fitch said.

WATCH:Top 5 stories of this morning; From Infosys to relocate 3,000 employees to RJio approaches TRAI over license breach by telcos

WATCH:Top 5 stories of this morning; From Infosys to relocate 3,000 employees to RJio approaches TRAI over license breach by telcos

Wed, Aug 17, 2016

Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Top five stories of this morning: 1. SGX Nifty in red amid weak global cues

Sun, Dr Reddy's, Glenmark strengthen their US play

Sun, Dr Reddy's, Glenmark strengthen their US play

Mon, Jul 18, 2016

Domestic pharma players are in stiff competition in US market. Sun Pharma with its taking over of SPARC's ELEPSIA XR, while Dr. Reddy launching Omeprazole and Sodium bicarbonate capsules and that of Glenmark waiting for 62 ANDA's approval, plans to strenghthen their position in the US.

Pharma likely to see double-digit revenue growth in first quarter

Pharma likely to see double-digit revenue growth in first quarter

Tue, Jul 12, 2016

Surya Patra and Mehul Sheth of Phillip Capital said, in Q1FY17, pharma industry to see top-line and bottom-line growth by 16% and 24% respectively, primarily due to robust performance from Sun Pharma, led by its product gGleevec.

These top six companies together added Rs 22,459 crore in market valuation

These top six companies together added Rs 22,459 crore in market valuation

Sun, Jun 19, 2016

Sun Pharma added Rs 288.8 crore to Rs 1,78,769.24 crore.

Sun Pharma fourth quarter profit almost doubles but misses estimates

Sun Pharma fourth quarter profit almost doubles but misses estimates

Tue, May 31, 2016

Net profit for the world`s fifth-largest generic drugs maker in the January-March quarter jumped to 17.1 billion rupees ($255 million) from 8.9 billion rupees in the same period a year earlier. But that was below a Thomson Reuters StarMine SmartEstimate of 19.14 billion rupees.

CCI approves PVR-DT Cinemas' Rs 500 crore deal, asks to exclude certain assets

CCI approves PVR-DT Cinemas' Rs 500 crore deal, asks to exclude certain assets

Sat, May 07, 2016

In a regulatory filing, DLF said now, the deal will exclude seven screens in Saket and Greater Kailash in South Delhi.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x